Trial
NCT00420810
Adult Polysomnography Primary Insomnia Cross Over Study (0928-049)(TERMINATED)
Phase IIITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
H. Lundbeck A/S
Collaborators
—
Condition
Primary Insomnia
Intervention
MK0928 / Duration of Treatment : 8 Weeks
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-01-14